Patient-derived MicroOrganoSpheres (MOS)TM enable precision clinical decision-making for multiple myeloma patients
Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development
Feasibility of establishing and drug screening patient-derived rectal organoid models from pretreatment rectal cancer biopsies